SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 1999. Upgrade now.
Date Value
June 30, 2024 581.80M
March 31, 2024 534.20M
December 31, 2023 477.10M
September 30, 2023 508.10M
June 30, 2023 478.90M
March 31, 2023 490.40M
December 31, 2022 482.10M
September 30, 2022 446.80M
June 30, 2022 457.50M
March 31, 2022 428.80M
December 31, 2021 467.00M
September 30, 2021 497.80M
June 30, 2021 455.00M
March 31, 2021 448.10M
December 31, 2020 423.90M
September 30, 2020 370.40M
June 30, 2020 403.50M
March 31, 2020 337.20M
December 31, 2019 336.20M
September 30, 2019 310.20M
June 30, 2019 320.90M
March 31, 2019 364.40M
December 31, 2018 265.80M
September 30, 2018 345.70M
June 30, 2018 282.80M
Date Value
March 31, 2018 267.10M
December 31, 2017 330.10M
September 30, 2017 310.50M
June 30, 2017 363.40M
March 31, 2017 368.20M
December 31, 2016 316.80M
September 30, 2016 326.00M
June 30, 2016 208.60M
March 31, 2016 246.40M
December 31, 2015 452.70M
September 30, 2015 384.55M
June 30, 2015 604.35M
March 31, 2015 562.38M
December 31, 2014 381.30M
September 30, 2014 457.93M
June 30, 2014 349.54M
March 31, 2014 352.87M
December 31, 2013 394.01M
September 30, 2013 276.90M
June 30, 2013 251.42M
March 31, 2013 233.31M
December 31, 2012 201.75M
September 30, 2012 219.38M
June 30, 2012 167.41M
March 31, 2012 138.01M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

310.20M
Minimum
Sep 2019
581.80M
Maximum
Jun 2024
446.75M
Average
456.25M
Median

SG&A Expense (TTM) Benchmarks

Liquidia Corp 67.90M
Catalent Inc 935.00M
Amgen Inc 7.22B
Merck & Co Inc 10.54B
AbbVie Inc 13.26B